newsfilter
← Latest News
GlobeNewswire·

Adamis Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid overdose, respiratory and inflammatory disease, today announ